UPC
Universe Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$1.47
−1.34%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.58
From 52W high−87.93%
Volume40982.00
Market cap$7.39M
P/E (TTM)—
P/S (TTM)0.4x
Div yield—
Key dataNov 4, 2026
Open
$1.58
From 52W high
−87.93%
Volume
40982.00
Market cap
$7.39M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
9.3x
P/E (TTM)
—
RSI (14)
23.1
MomentumView details →
1D Return
−1.34%
YTD Return
−60.37%
SummaryUpdated Mar 1, 2026
Universe Pharmaceuticals INC (NASDAQ:UPC) is a Chinese pharmaceutical company founded in 2019 and headquartered in Ji'An, China. The company went public on the NASDAQ in March 2021. Universe Pharmaceuticals operates as a subsidiary of Sununion Holding Group Limited and specializes in manufacturing, marketing, and distributing traditional Chinese medicine derivative products primarily within the Chinese market. Despite being a relatively young public company, Universe Pharmaceuticals has established itself in the specialty pharmaceutical sector, focusing on products that address common chronic health conditions in elderly populations as well as cold and flu treatments.
Similar companies
Latest newsMore news →
The Law Offices of Howard G. Smith announced an investigation into potential claims against Universe Pharmaceuticals INC's board over alleged breaches of fiduciary duties to shareholders.23d agoLaw Offices of Frank R. Cruz announced an investigation into potential claims against Universe Pharmaceuticals INC's board over alleged breaches of fiduciary duties to shareholders.28d agoUniverse Pharmaceuticals agreed to acquire Best Praise for $10.75 million.131d ago